-
Something wrong with this record ?
Pancreatic cancer: branched-chain amino acids as putative key metabolic regulators
L. Rossmeislová, J. Gojda, K. Smolková
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
NLK
ProQuest Central
from 1997-06-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2009-12-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-06-01 to 1 year ago
Public Health Database (ProQuest)
from 1997-06-01 to 1 year ago
- MeSH
- Diabetes Mellitus * MeSH
- Carcinoma, Pancreatic Ductal * etiology pathology MeSH
- Insulin Resistance * MeSH
- Cachexia etiology MeSH
- Humans MeSH
- Pancreatic Neoplasms * pathology MeSH
- Obesity complications metabolism MeSH
- Amino Acids, Branched-Chain metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Branched-chain amino acids (BCAA) are essential amino acids utilized in anabolic and catabolic metabolism. While extensively studied in obesity and diabetes, recent evidence suggests an important role for BCAA metabolism in cancer. Elevated plasma levels of BCAA are associated with an increased risk of developing pancreatic cancer, namely pancreatic ductal adenocarcinoma (PDAC), a tumor with one of the highest 1-year mortality rates. The dreadful prognosis for PDAC patients could be attributable also to the early and frequent development of cancer cachexia, a fatal host metabolic reprogramming leading to muscle and adipose wasting. We propose that BCAA dysmetabolism is a unifying component of several pathological conditions, i.e., obesity, insulin resistance, and PDAC. These conditions are mutually dependent since PDAC ranks among cancers tightly associated with obesity and insulin resistance. It is also well-established that PDAC itself can trigger insulin resistance and new-onset diabetes. However, the exact link between BCAA metabolism, development of PDAC, and tissue wasting is still unclear. Although tissue-specific intracellular and systemic metabolism of BCAA is being intensively studied, unresolved questions related to PDAC and cancer cachexia remain, namely, whether elevated circulating BCAA contribute to PDAC etiology, what is the biological background of BCAA elevation, and what is the role of adipose tissue relative to BCAA metabolism during cancer cachexia. To cover those issues, we provide our view on BCAA metabolism at the intracellular, tissue, and whole-body level, with special emphasis on different metabolic links to BCAA intermediates and the role of insulin in substrate handling.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22019612
- 003
- CZ-PrNML
- 005
- 20220804135826.0
- 007
- ta
- 008
- 220720s2021 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10555-021-10016-0 $2 doi
- 035 __
- $a (PubMed)34962613
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Rossmeislová, Lenka $u Department of Pathophysiology, Center for Research On Nutrition, Metabolism, and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Franco-Czech Laboratory for Clinical Research On Obesity, Third Faculty of Medicine, Prague, Czech Republic $1 https://orcid.org/0000000276117585 $7 xx0095550 $7 xx0102461
- 245 10
- $a Pancreatic cancer: branched-chain amino acids as putative key metabolic regulators / $c L. Rossmeislová, J. Gojda, K. Smolková
- 520 9_
- $a Branched-chain amino acids (BCAA) are essential amino acids utilized in anabolic and catabolic metabolism. While extensively studied in obesity and diabetes, recent evidence suggests an important role for BCAA metabolism in cancer. Elevated plasma levels of BCAA are associated with an increased risk of developing pancreatic cancer, namely pancreatic ductal adenocarcinoma (PDAC), a tumor with one of the highest 1-year mortality rates. The dreadful prognosis for PDAC patients could be attributable also to the early and frequent development of cancer cachexia, a fatal host metabolic reprogramming leading to muscle and adipose wasting. We propose that BCAA dysmetabolism is a unifying component of several pathological conditions, i.e., obesity, insulin resistance, and PDAC. These conditions are mutually dependent since PDAC ranks among cancers tightly associated with obesity and insulin resistance. It is also well-established that PDAC itself can trigger insulin resistance and new-onset diabetes. However, the exact link between BCAA metabolism, development of PDAC, and tissue wasting is still unclear. Although tissue-specific intracellular and systemic metabolism of BCAA is being intensively studied, unresolved questions related to PDAC and cancer cachexia remain, namely, whether elevated circulating BCAA contribute to PDAC etiology, what is the biological background of BCAA elevation, and what is the role of adipose tissue relative to BCAA metabolism during cancer cachexia. To cover those issues, we provide our view on BCAA metabolism at the intracellular, tissue, and whole-body level, with special emphasis on different metabolic links to BCAA intermediates and the role of insulin in substrate handling.
- 650 _2
- $a větvené aminokyseliny $x metabolismus $7 D000597
- 650 _2
- $a kachexie $x etiologie $7 D002100
- 650 12
- $a duktální karcinom slinivky břišní $x etiologie $x patologie $7 D021441
- 650 12
- $a diabetes mellitus $7 D003920
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a inzulinová rezistence $7 D007333
- 650 _2
- $a obezita $x komplikace $x metabolismus $7 D009765
- 650 12
- $a nádory slinivky břišní $x patologie $7 D010190
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Gojda, Jan $u Franco-Czech Laboratory for Clinical Research On Obesity, Third Faculty of Medicine, Prague, Czech Republic $u Department of Internal Medicine, Královské Vinohrady University Hospital and Third Faculty of Medicine, Prague, Czech Republic $1 https://orcid.org/0000000279955947
- 700 1_
- $a Smolková, Katarína $u Laboratory of Mitochondrial Physiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic. katarina.smolkova@fgu.cas.cz $1 https://orcid.org/0000000247340200 $7 xx0139595
- 773 0_
- $w MED00009430 $t Cancer metastasis reviews $x 1573-7233 $g Roč. 40, č. 4 (2021), s. 1115-1139
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34962613 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135819 $b ABA008
- 999 __
- $a ok $b bmc $g 1822997 $s 1170855
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 40 $c 4 $d 1115-1139 $e 20211228 $i 1573-7233 $m Cancer metastasis reviews $n Cancer Metastasis Rev $x MED00009430
- LZP __
- $a Pubmed-20220720